Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 3
1954 3
1956 2
1959 1
1961 16
1962 18
1963 19
1964 22
1965 23
1966 13
1967 32
1968 27
1969 32
1970 39
1971 40
1972 36
1973 29
1974 48
1975 30
1976 32
1977 53
1978 50
1979 51
1980 57
1981 66
1982 65
1983 74
1984 86
1985 116
1986 123
1987 120
1988 150
1989 155
1990 148
1991 138
1992 152
1993 162
1994 177
1995 176
1996 167
1997 204
1998 227
1999 186
2000 243
2001 247
2002 208
2003 253
2004 233
2005 246
2006 231
2007 271
2008 266
2009 247
2010 312
2011 305
2012 297
2013 285
2014 295
2015 288
2016 301
2017 315
2018 325
2019 299
2020 368
2021 463
2022 466
2023 363
2024 408
2025 434
2026 130

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,535 results

Results by year

Filters applied: . Clear all
Page 1
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Ohba A, et al. Among authors: kobayashi s. J Clin Oncol. 2025 Nov;43(31):3345-3354. doi: 10.1200/JCO.24.00936. Epub 2025 Jul 28. J Clin Oncol. 2025. PMID: 40720715 Free PMC article. Clinical Trial.
Risk factors for the development of knee osteoarthritis across the lifespan: A systematic review and meta-analysis.
Duong V, Abdel Shaheed C, Ferreira ML, Narayan SW, Venkatesha V, Hunter DJ, Zhu J, Atukorala I, Kobayashi S, Goh SL, Briggs AM, Cross M, Espinosa-Morales R, Fu K, Guillemin F, Keefe F, Stefan Lohmander L, March L, Milne GJ, Mei Y, Mobasheri A, Namane M, Peat G, Risberg MA, Sharma S, Sit R, Telles RW, Zhang Y, Cooper C. Duong V, et al. Among authors: kobayashi s. Osteoarthritis Cartilage. 2025 Oct;33(10):1162-1179. doi: 10.1016/j.joca.2025.03.003. Epub 2025 Mar 31. Osteoarthritis Cartilage. 2025. PMID: 40174718 Free article.
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer.
Yamamoto G, Tanaka K, Kamata R, Saito H, Yamamori-Morita T, Nakao T, Liu J, Mori S, Yagishita S, Hamada A, Shinno Y, Yoshida T, Horinouchi H, Ohe Y, Watanabe SI, Yatabe Y, Kitai H, Konno S, Kobayashi SS, Ohashi A. Yamamoto G, et al. Among authors: kobayashi ss. Cancer Lett. 2024 Dec 24;611:217414. doi: 10.1016/j.canlet.2024.217414. Online ahead of print. Cancer Lett. 2024. PMID: 39725152 Free article.
Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity.
Sonehara K, Uwamino Y, Saiki R, Takeshita M, Namba S, Uno S, Nakanishi T, Nishimura T, Naito T, Sato G, Kanai M, Liu A, Uchida S, Kurafuji T, Tanabe A, Arai T, Ohno A, Shibata A, Tanaka S, Wakui M, Kashimura S, Tomi C, Hara A, Yoshikawa S, Gotanda K, Misawa K, Tanaka H, Azekawa S, Wang QS, Edahiro R, Shirai Y, Yamamoto K, Nagao G, Suzuki T, Kiyoshi M, Ishii-Watabe A, Higashiue S, Kobayashi S, Yamaguchi H, Okazaki Y, Matsumoto N, Masumoto A, Koga H, Kanai A; Japan COVID-19 Task Force; Biobank Japan Project; Oda Y, Suzuki Y, Matsuda K, Kitagawa Y, Koike R, Kimura A, Kumanogoh A, Yoshimura A, Imoto S, Miyano S, Kanai T, Fukunaga K, Hasegawa N, Murata M, Matsushita H, Ogawa S, Okada Y, Namkoong H. Sonehara K, et al. Among authors: kobayashi s. Cell Genom. 2025 Mar 12;5(3):100783. doi: 10.1016/j.xgen.2025.100783. Epub 2025 Mar 4. Cell Genom. 2025. PMID: 40043710 Free PMC article.
A cross-population compendium of gene-environment interactions.
Namba S, Sonehara K, Koyanagi YN, Kikuchi T, Ojima T, Edahiro R, Sato G, Yamaji T, Tomofuji Y, Ueda H, Yamamoto K, Ogawa Y, Suzuki K, Kanai A, Higashiue S, Kobayashi S, Yamaguchi H, Nagata Y, Okazaki Y, Matsumoto N, Motomura K, Koga H, Hishida A, Ikezaki H, Hara M, Nagayoshi M, Oze I, Nakano S; BioBank Japan Project; Oda Y, Suzuki Y, Iwasaki M, Sawada N, Matsuo K, Morisaki T, Yamauchi T, Kadowaki T, Matsuda K, Okada Y. Namba S, et al. Among authors: kobayashi s. Nature. 2026 Jan 28. doi: 10.1038/s41586-025-10054-6. Online ahead of print. Nature. 2026. PMID: 41606330
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.
Tajima K, Hosonuma M, Funayama E, Isobe J, Baba Y, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Maruyama Y, Sasaki A, Amari Y, Yamazaki Y, Nakashima R, Shida M, Sasaki A, Sambe T, Wada S, Tsuji M, Kiuchi Y, Kobayashi S, Kuramasu A, Tsunoda T, Mori M, Koyanagi K, Yoshimura K. Tajima K, et al. Among authors: kobayashi s. Int J Cancer. 2025 Sep 1;157(5):993-1005. doi: 10.1002/ijc.35472. Epub 2025 Jun 6. Int J Cancer. 2025. PMID: 40478177
Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β.
Fukumoto K, Hikita H, Saito Y, Makino Y, Soma K, Kato S, Sasaki Y, Myojin Y, Sato K, Sakane S, Murai K, Tahata Y, Kodama T, Tatsumi T, Motooka D, Kubota Y, Kobayashi S, Eguchi H, Takehara T. Fukumoto K, et al. Among authors: kobayashi s. Cell Mol Gastroenterol Hepatol. 2025 Dec 2;20(4):101698. doi: 10.1016/j.jcmgh.2025.101698. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2025. PMID: 41344438 Free PMC article.
10,535 results
You have reached the last available page of results. Please see the User Guide for more information.